Become a Member

Abbott Laboratories (ABT)

Healthcare • Medical - Devices

48
Beobachten
$109,41
Price
+0,10%
Change
190,42 Mrd. $
Market Cap
-
P/E Ratio

Neumann-Score Stock Analysis

48
out of 100
Beobachten
Valuation??/100
Profitability??/100
Growth??/100

Unlock Score Details

Become a member and get access to all analyses.

Become a Member

About Abbott Laboratories

Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon ...

CEO
Robert Ford
Employees
114.000
Country
US